FDA to create and staff inspection offices in China, India

Share this article:
The FDA plans to create and staff inspection offices throughout China and India, and possibly other countries, as a means to step up its regulatory enforcement of the growing inventory of drug products being made abroad, commissioner Andrew von Eschenbach told a House Energy and Commerce subcommittee hearing.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Legal/Regulatory

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.